• MedAdvisor sells ANZ business to Jonas Software for ~$42.35 million
• Upfront consideration of $27 million, with $8 million holdback and uncapped earn-out potential
• MedAdvisor to focus on US business, evaluating strategic options

MedAdvisor Limited (ASX: MDR) has announced the successful completion of the sale of its ANZ business division and associated intellectual property to Jonas Software AUS Pty Ltd (Jonas) for a total estimated consideration of ~$42.35 million. The transaction includes an upfront payment of $27 million, a holdback amount of $8 million, and an uncapped earn-out potential estimated at $7.35 million based on the performance of the ANZ business over the next three years. The completion of the sale follows the company's announcement on 2 July 2025 that it had entered into a binding share sale and purchase agreement with Jonas, pending the satisfaction of certain pre-completion conditions. As part of the transaction, MedAdvisor's US business will continue to operate under a royalty-free licence arrangement with Jonas. MedAdvisor Limited, which owns and operates the US business, will remain listed on the ASX. The company also announced that Mrs Ancila Desai will step down from her role as Chief Financial Officer at the conclusion of her notice period, with an appointment of a new CFO for the Australian business expected shortly. With the completion of this transaction, MedAdvisor Solutions is now sharpening its focus on the US business, while continuing to evaluate options for the US operations.

MedAdvisor Solutions remains confident in the strength of its US platform, the depth of its client relationships, and the strategic investments positioning it for long-term growth, despite near-term market headwinds. The company will continue to evaluate options for the US business and provide updates to the market in due course.